Public biotechnology 2005--the numbers.
Although investors remained cautious of public biotech companies in 2005, acquisitions and research partnerships were on the up.
Lähteenmäki
Riku
R
Lawrence
Stacy
S
D001709:Biotechnology / Q000191:economics* / Q000706:statistics & numerical data* / Q000639:trends; D005060:Europe; D007182:Income / Q000706:statistics & numerical data* / Q000639:trends; D007221:Industry / Q000191:economics* / Q000706:statistics & numerical data* / Q000639:trends; D017150:Public Sector / Q000191:economics* / Q000706:statistics & numerical data*; D014481:United States